Gao, R. W., Day, C. N., Yu, N. Y., Bush, A., Amundson, A. C., Prodduturvar, P., Majeed, U., Butts, E., Oliver, T., Schwecke, A. J., Moffett, J. N., Routman, D. M., Breen, W. G., Potter, A. L., Rivera-Concepcion, J., Hoppe, B. S., Schild, S. E., Sio, T. T., Lou, Y., Ernani, V., Ko, S., Olivier, K. R., Merrell, K. W., Garces, Y. I., Manochakian, R., Harmsen, W. S., Leventakos, K., & Owen, D. (2022). dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab. Lung cancer, 170, 58–64. http://access.bl.uk/ark:/81055/vdc_100160177067.0x000043